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Summary 
Immune interactions in the heart were studied using a murine model of myosin-induced au- 
toimmune myocarditis. A T  cell hybridoma specific for mouse cardiac myosin was generated 
from A/J mice and used to demonstrate that endogenous myosin/I-A  k complexes are constitu- 
tively expressed on antigen-presenting cells in the heart.  This T  cell hybridoma, Seu.5, was 
used as a functional probe to identify a myocarditis-inducing epitope of cardiac myosin. Over- 
lapping peptides based on the cardiac myosin heavy chain cx (myhcot) sequences were synthe- 
sized and  tested for their ability to  stimulate  Seu.5  T  cells.  One peptide,  myhco~(325-357) 
strongly stimulated the Seu.5 T  cells, localizing the epitope to this region of the myhca mole- 
cule.  Using  truncated peptides,  the  epitope was  further localized to  residues 334-352.  The 
myhccx(334-352) peptide strongly induced myocarditis when administered to A/J mice, which 
was  histologically  indistinguishable  from  that  induced  by  myosin.  The  myhcot(334-352) 
epitope was present in cardiac myosin and not skeletal muscle myosins, providing a biochemi- 
cal basis for the cardiac specificity of this autoimmune disease. Induction of myocarditis by this 
epitope was restricted to the myhcot isoform and not the myhc[3 isoform, suggesting there may 
be a difference in the efficiency of generating tolerance to these isoforms of cardiac myosin, 
which  are  differentially developmentally regulated.  The myhcot(334-352)  epitope bound  to 
purified I-A  k molecules in a similar manner to other I-Ak-restricted immunogenic epitopes, 
HEL(48-61) and R.Nase(43-56).  Importantly, the myhc0~(334-352) epitope was able to bind 
to I-A  k molecules on the surface of antigen-presenting cells in a stable manner. These findings 
demonstrate that autoantigenic epitopes can behave in a dominant manner and constitutively 
bind to  class II  molecules in  the  target organ in  a  similar manner to foreign immunogenic 
epitopes. 
A 
n  important  property  of the  immune  system  is  the 
ability to distinguish self from nonself. Normally this 
discrimination occurs very e~ciently; however, under cer- 
tain  circumstances autoimmune  responses  develop.  Many 
explanations have been proposed to explain these autoim- 
mune responses, including failures  in central or peripheral 
tolerance, molecular mimicry between a  pathogen  and  a 
self-antigen, and inadequate regulatory mechanisms  (1-3). 
Despite an intense research effort in this area by numerous 
laboratories, the cellular and molecular basis for the induc- 
tion ofautoimmune diseases is unknown. The study ofau- 
toimmunity has been greatly facilitated by the development 
of rodent models ofautoimmune disease and the identifica- 
tion of the  autoantigenic epitopes involved in  disease  in- 
duction (4-7).  For example, in the study of experimental 
autoimmune encephalomyelitis, identification of the disease- 
inducing epitopes has resulted in a significant advancement 
in our understanding ofautoimmune processes (8-10). 
We  have a long-standing interest in how the  immune 
system induces cardiac damage, and have used the model of 
myosin-induced  myocarditis  to  study  these  interactions 
(11-13). This model was based on the observation that au- 
toantibodies  against  cardiac  myosin were  found in  Cox- 
sackievirus B3-infected mice with myocarditis, suggesting 
cardiac myosin as a candidate autoantigen in autoimmune 
heart disease  (14). Immunization of mice with purified car- 
diac myosin resulted in the induction of myocarditis with 
similar pathology to that observed in the  Coxsackievirus- 
infected mice (15).  We have previously demonstrated that 
myosin-induced  autoimmune  myocarditis  is  a  CD4 +  T 
cell-mediated disease,  as  depletion of CD4 +  T  cells  pre- 
vented  induction  of myocarditis  and  transfer  of purified 
myosin-reactive T  cells into SCID mice resulted in myo- 
carditis in the absence of anti-myosin antibodies  (1l). We 
further explored the  requirements for myocarditis induc- 
tion and used T cell hybridomas specific for cardiac myosin 
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pressed  on  endogenous  Ia  +  APC  in  the  normal  mouse 
heart (13). Thus, in this model, tissue injury is not required 
for  expression  of the  autoantigen  because  the  myosin/Ia 
complexes are constitutively present in the heart. 
In this report, we have extended our previous work with 
myosin-specific T  cells, and  used these  cells as functional 
probes to identify an epitope of myosin that induces auto- 
immune myocarditis in mice. We generated a cardiac myo- 
sin-specific T  cell hybridoma in A/J mice which detected 
myosin/Ia complexes that were constitutively expressed in 
the normal A/J heart. We then used a series of overlapp- 
ing peptides corresponding to  the  myosin heavy  chain  oL 
(myhco01  sequence  to  identify the  epitope recognized by 
this  T  cell.  This  myosin  epitope  induced  myocarditis in 
A/J mice,  and bound to  I-A  k molecules in an  SDS-stable 
conformation on the surface of APCs. These findings show 
this is an immunodominant  epitope because it is constitu- 
tively expressed and stably bound to  class II molecules on 
normal APC in the target organ of this disease model, and 
suggest  that  autoantigenic  epitopes  can  be  presented  in  a 
dominant  manner.  The  stable  expression  of autoantigen 
within the target organ in this model of autoimmune disease 
suggests that the important steps in the induction of myo- 
carditis occur at the level ofT  cell and/or APC activation. 
Materials and Methods 
T  Cell Hybridomas and T  Cell Assays.  Myosin-specific T  cell 
hybridomas were generated from myosin-immunized A/J mice as 
described previously  (13).  Briefly,  A/J  mice  were  immunized 
subcutaneously with 150 p~g ofmyosin/CFA on days 0 and 7. On 
day  14  the  draining lymph nodes were  removed and the  cells 
stimulated  in  vitro  for  7  d  with  cyanogen  bromide-digested 
mouse  cardiac  myosin  (5  I*g/ml)  and  then  restimulated  with 
APC,  antigen, and IL-2 for an additional 6  d.  The  viable cells 
were then fused to the TCR-~x-/IB- BW5147 thymoma cells and 
myosin-specific T cells were identified by their ability to produce 
IL-2 upon stimulation with myosin. The reactive T cell hybrido- 
mas were subcloned and MHC restriction was determined as pre- 
viously described (13). 
The T  cell hybridoma assay was performed as described previ- 
ously (16). The level of IL-2 production by the T cell hybridomas 
was ascertained by  [3H]thymidine incorporation into the  IL-2- 
dependent CTLL-2 cells. 
Peptides.  Peptides were synthesized, purified, and analyzed as 
previously  described  (17).  The  peptides  were  synthesized  on 
either an ABI model 432A (Perkin-Elmer, Foster City, CA), or 
a Symphony/Multiplex synthesizer (Rainin Instrument Co., Wo- 
burn, MA) using standard 9-fluorenylmethoxycarbonyl chemistry. 
The  reagents  for  peptide synthesis were  purchased  from  ABI, 
R.ainin, and Advanced ChemTech (Louisville, KY). The peptides 
were  purified  by  C18  reverse-phase  HPLC  and  their  identity 
confirmed by  amino  acid analysis  (model  6300;  Beckman  In- 
struments, Palo Alto, CA) and mass spectrometry (Protein Chem- 
istry Laboratory, Washington University, St. Louis, MO), except 
the one series  of 33 mers which were not HPLC purified. The 
tAbbreviations used in this paper: MBP, myelin basic protein; mych~x, myo- 
sin heavy chain ~x. 
concentration  of each  peptide was  determined by  amino  acid 
analysis. 
Myosin.  Mouse  cardiac  myosin  was  purified  following  a 
modified procedure of Shiverick et al. (18). The myosin was sol- 
ubilized and stored in 50 mM sodium pyrophosphate. The cyan- 
ogen bromide digest of myosin was prepared as previously de- 
scribed (13). 
APCs.  The  CH27  antigen-presenting B  cell line  (19),  car- 
diac APCs from normal A/J mice (13), and spleen cells (13) were 
prepared and used as described. Cardiac APCs are bone marrow- 
derived cells,  ~15%  of which  express  MHC  class  II  antigens, 
with the predominant APC being dendritic cells (20, 21). 
Induction  and  Quantitation  of Autoimmune  Myocarditis.  Myo- 
carditis was induced as described previously (11). Briefly, male A/J 
mice were injected subcutaneously with 100 Izg of cardiac myo- 
sin emulsified in CFA on days 0 and 7.  On day 0 the mice were 
also injected intraperitoneally with 500 ng of pertussis  toxin (List 
Biochemicals, Campbell, CA). Mice receiving the myhca pep- 
tides were immunized with 50-150 nmol of the peptides emulsi- 
fied in CFA in an identical manner, and received 500  ng ofper- 
tussis toxin as above. Immunization with higher concentrations of 
the peptides did not result in increased severity of myocarditis. 
The mice were killed on day 21 and the hearts were prepared for 
histologic examination. Serial step sections were made through 
the entire heart and stained with hematoxylin and eosin. Every 
fifth  section was  examined for the  presence  of myocarditis by 
light microscopy, and was evaluated according to previously pub- 
lished criteria describing the severity ofmyocarditis as follows: se- 
vere  =  >50%  of the heart involved, moderate  =  10-50%  in- 
volved, minimal =  < 10% involved, or normal (11). 
Peptide Binding to Ia Molecules.  The binding of peptide anti- 
gens to purified I-A  k molecules was determined using a competi- 
tive  binding  assay  as  previously  described  in  detail  (22,  23). 
Briefly, 25  pmol purified I-A  k molecules were  incubated with 
0.25 pmo112SI-labeled-HEL(YE52-61) in a total volume of 25 txl 
in the absence or presence of an unlabeled peptide. A  range of 
concentrations  (10-1,000  pmol) of the peptides were tested for 
their ability to  inhibit the binding of the labeled HEL peptide 
compared to the ability of the unlabeled HEL peptide to inhibit 
binding to purified I-A  k. The level of labeled HEL bound to I-A  k 
was determined by Bio Spin P6 chromatography (Bio Rad Labo- 
ratories, Hercules,  CA)  (24).  In a typical experiment 50,000  to 
150,000  cpm of the peptide bound in the absence of competitor 
peptides, representing 25-40% of the input. 
Ia Stability.  The ability of peptides to induce a stable confor- 
mation of I-A  k on the surface  of APCs was determined using the 
SDS/PAGE stability assay as described (23,  25,  26).  Briefly, ra- 
diolabeled peptides  were  incubated  with  the  I-Ak-expressing 
M12.C3.F6 B-lymphoma cells for 4 h. The cells were then har- 
vested, washed, and lysed in PBS containing 1% Triton X-100, 
10 mM iodoacetamide, 1 mM PMSF, and 20 I,  Lg/ml of leupep- 
tin. The lysate was incubated with the monoclonal anti-I-A  k anti- 
body  10.3.6.2  and  the  immunoprecipitates  were  analyzed  by 
SDS/PAGE. The SDS stable I-A  k molecules were visualized by 
autoradiography. The  level of l-A  k stability induced was deter- 
mined by quantitating the stable and unstable bands using a ph- 
osphoimage analysis  system (Molecular Dynamics, Inc.,  Sunny- 
vale, CA). 
Results 
Generation  and  Characterization  of a Myosin-specific  T  Cell 
Hybridoma.  T  cell hybridomas were  generated from  A/J 
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functional  probes  in  the  identification  of a  myocarditis- 
inducing  epitope.  One  T  cell  hybridoma,  Seu.5,  was  se- 
lected for further characterization.  Seu.5 strongly reacted to 
murine  cardiac  myosin  (Fig.  1  A).  This  hybridoma  was 
CD4  dependent,  did  not respond  to  actin,  troponin,  tro- 
pomyosin, or myosin light chain, and was restricted by the 
I-A  k molecule  (data  not shown).  Previous  studies  demon- 
strated that myocarditis in A/J mice was an I-A~-mediated 
disease (11). Thus, we had generated a cardiac myosin-spe- 
cific T  cell hybridoma, specific for the autoantigen and re- 
stricted  by  the  appropriate  MHC  molecule,  which  we 
could use as a probe to identify an epitope involved in the 
induction of myocarditis. 
We have previously shown that cardiac myosin is consti- 
tutively processed and presented by cardiac APCs using an 
I-Ad-restricted myosin-specific T  cell hybridoma (13). We 
next  determined  if the  epitope  recognized  by  Seu.5  was 
also  processed  and  presented  in  the  hearts  of normal  A/J 
mice.  As shown  in  Fig.  1  B,  residential  A/J  cardiac APCs 
strongly  stimulated  Seu.5  T  cells.  The  expression  of the 
myosin-I-A  k  complexes  was  tissue  specific  because  no 
complexes  were  detected  by  Seu.5  T  cells  in  the  spleens 
from the same animals  (Fig.  1  C).  These findings indicated 
that  the  myosin  epitope  recognized  by  Seu.5  is  constitu- 
tively processed  and  presented  in  the  target  organ  of this 
model ofautoimmune myocarditis. 
Identification of the Region of Myosin Recognized by Seu. 5. 
To identify the epitope of myosin recognized by Seu.5, we 
synthesized  a  series  of peptides  based  on  the  A/J  murine 
cardiac  myhco~ isoform sequence  (27).  None  of the  pep- 
tides  in  a  series  of overlapping peptides  covering residues 
1-149 stimulated Seu.5 (data not shown). We then synthe- 
sized  24  peptides  encompassing  residues  145-637  of the 
myhco~ sequence,  each 33  amino  acids long with  overlaps 
of 13  amino  acid residues.  Each of the  peptides  was  then 
tested  for its  ability  to  stimulate  Seu.5  and  the  results  are 
shown  in  Fig.  2.  One  of the  peptides,  myhcct(325-357), 
strongly stimulated Seu.5, whereas none of the others stim- 
ulated  Seu.5.  Thus,  the  myhc0~  epitope  recognized  by 
Seu.5 was contained within the peptide 325-357 (Fig. 3 A). 
Characterization  of  the  myhce~(325-357)  Determinant. 
To  identify  the  actual  Seu.5  stimulatory  determinant,  we 
generated  a  series  of truncated  peptides  based  upon  the 
myhcc~(325-357) sequence  (Fig. 3 A). The inability of the 
overlapping  peptides  myhce~(305-337)  and  myhcot(345- 
377) to stimulate Seu.5  (Fig. 2), suggested that the stimula- 
tory epitope  was  not  contained  in  the  amino  or carboxy 
terminal regions of the myhcot(325-357) sequence.  There- 
fore, we initially focused on the central portion of the 325- 
357  epitope by synthesizing the peptide  myhca(334-352). 
The  myhcoL(334-352) peptide  stimulated  Seu.5  T  cells  as 
strongly  as  the  myhc0t(325-357),  indicating  that  the  epi- 
tope was contained within this 19 mer (Fig. 3 B). The opti- 
mal length of class  II-restricted epitopes varies, but is gen- 
erally  13-15  amino  acids.  To  identify the  optimal length 
of the  Seu.5  epitope,  we  generated  truncated  peptides  of 
the  myhce~(334--352)  sequence  (Fig.  3  A).  The  14  mer, 
myhc0~(335-348) peptide strongly stimulated Seu.5 T  cells, 
whereas the same length peptide  shifted one amino acid in 
register,  myhcot(334-347), was completely nonstimulatory 
(Fig.  3  B).  This  failure  to stimulate  appeared  to be  due to 
the  lack  of the  A348  residue,  since  the  peptide  myhcc~ 
(334-348) was strongly stimulatory. Thus, we had localized 
the Seu.5 stimulatory myhcc~ epitope to the 14--amino acid 
peptide myhco~(335-348). 
Figure 1.  Reactivity of Seu.5 T cell hybridoma. (A) Seu.5 recognizes  mouse cardiac myosin. Seu.5 T cells (105) were stimulated for 20 h with CNBr- 
digested mouse cardiac myosin at the indicated concentrations using CH27 cells (3 ￿  104) as the APC as described in Materials and Methods. The level 
of stimulation was determined by quantitating the level of IL-2 production by [3H]thymidine  incorporation in the IL-2-dependent cell line, CTLL-2. 
Stimulation by APC without any antigen resulted in <200 cpm. The values represent the mean +/-  standard deviation of triplicate determinations. 
Identical results were obtained in at least three separate experiments. (B) Seu.5 recognizes myosin/l-A  k complexes expressed constitutively on cardiac 
APCs. Seu.5 cells were stimulated with increasing numbers of  purified cardiac APCs (CAPC)  from A/J mice without the addition of exogenous antigen 
as described in A. The values represent the mean +/-  standard deviation of  triplicate determinations. Identical  results were obtained in three separate ex- 
periments. (C) Endogenous myosin/I-A  k complexes are expressed in the heart but not in the spleen. Seu.5 T cells (105) were stimulated with (1) A/J 
CAPC (2 ￿  104/weU) with no additional antigen, (2) spleen cells (5 X 10  s) from the same mice alone, or (3) with the addition of 10 I.tg/ml of CNBr- 
digested mouse cardiac myosin. The values represent the mean +/-  standard deviation of triplicate determinations. Identical results were obtained in 
three separate experiments. 
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were stimulated with CH27  (3 X  10  4) APC and 0.5, 5, and 50 p,M of 
each of a series of 24 overlapping peptides covering the myhcct residues 
145-637 as described in Fig. 1. The amino acids covered by each peptide 
are given based on the myhcct sequence. The values shown are from the 
50-~M concentration. An identical pattern of reactivity of the peptides 
was observed at the other two concentrations tested. The values represent 
the  mean  of triplicate determinations.  The  standard deviations were 
< 15% of the mean. Similar results were obtained in two separate experi- 
ments. The very weak but detectable responses observed for 145-177, 
305-337, and 565-597 peptides were not observed in any other experi- 
ments, even when tested at higher concentrations. 
myhcc~(334-352)  Induces Myocarditis.  Having  identified 
the  myosin  epitope  recognized by  the  Seu.5  T  cells,  we 
next wanted to determine if this epitope could induce my- 
ocarditis.  When  A/J  mice  were  immunized  with  the 
myhctx(334-352)  peptide,  11  of 11  mice developed myo- 
carditis in  three separate experiments  (Fig. 4  A),  The  fre- 
quency and severity ofmyocarditis induced by myhcct (334- 
352)  was  similar  to  native  myosin  and  the  inflammatory 
lesions appeared histologically similar (Fig. 4  B),  although 
neutrophils were more common in myosin-induced disease 
than in peptide-induced disease. With the large size ofmy- 
hcot, it would be surprising if this disease was restricted to a 
single epitope.  However,  these  data indicate that myhcot- 
(335-348)  is  a  major  epitope  of myosin  involved  in  au- 
toimmune  myocarditis  because  immunization  with  this 
peptide  induced  significant  myocarditis.  Thus,  we  have 
identified an  epitope  of the  r  isoform  of cardiac myosin 
which is constitutively expressed on cardiac APC  and can 
induce autoimmune myocarditis. 
The  myhcce(334-352)  Determinant  Is  Cardiac  Specific. 
Autoimmune myocarditis is a cardiac-specific disease as im- 
munization with cardiac myosin results in myocarditis, and 
not  skeletal muscle  myositis (15).  Conversely,  immuniza- 
tion with skeletal myosin induces myositis, but no  cardiac 
inflammation (28).  One explanation for this tissue specific- 
ity is that the myocarditis-inducing epitope is expressed on 
cardiac myosins and not skeletal muscle myosins. To ascer- 
tain if this possibility was correct, we compared the myhc0t- 
(335-348)  sequence  to  the  corresponding region  of other 
cardiac and skeletal myosins. Vertebrate myosins are part of 
a multigene family comprised of at least 10 different mem- 
bers, all of which have a  conserved structure  (29).  Protein 
sequence alignments of the myosins revealed areas of com- 
plete  conservation  and  others  that  are  highly  divergent. 
The  334-352  region of myosin is not conserved between 
different myosin molecules (Fig. 5  A). Several positions in 
rat,  human,  and  mouse  myosins  differ in  this  region,  in- 
cluding both cardiac and skeletal myosins (Fig. 5 A  and not 
shown).  The  334-352  region  was  identical between  the 
three  described  allelic forms  of the  mouse  myhctx  gene 
(15, 27), consistent with them all being able to induce nly- 
ocarditis (11).  Thus,  the observed cardiac specificity of this 
autoimmune  disease can be explained by the myhcot(334- 
352)  sequence  only being expressed in the cardiac isoform 
of myosin heavy chain. 
Seu.5 Specifically Recognizes the myhcct Isoform of the (334- 
352) Epitope.  Two  isoforms of the  cardiac-specific myo- 
sin  heavy  chains  are  expressed  in  mammals,  myhc~,  and 
myhc[3.  The  myhcct(334-352)  determinant  differed  from 
the  murine  and  rat  myhcq3  sequences  at  positions  341, 
344,  and 348-350,  whereas rat myhcoL differed only at po- 
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Figure 3.  Seu.5 reactivity to myhc0r  and truncated peptides. (A) Sequence ofmyhcc~(325-357) and nested peptides. The amino acid sequence 
ofmyhcc~(325-357) and four shorter peptides are shown using the standard one-letter amino acid code. (B) Stimulation of Seu.5 by myhc0t(325-357) and 
truncated peptides. Seu.5 T cells (105) were stimulated with CH27 (3 X 104) APC and the indicated concentrations of each of the peptides shown in A 
as described in Fig. 1 A. The values represent the mean +/-  standard deviation of triplicate determinations. Identical results were obtained in at least 
four separate experiments. A, myhc~(325-357); ", myhcet(334-352); O, myhc~x(334-348); O, myhcc~(335-348);  ~, nwhceff334-347  ). 
1294  Myocarditis-inducing  Epitope Figure 4.  myhccx(334-352) induces myocarditis in A/J mice. (A) Summary of the severity ofmyocarditis induced by myhc~x(334-352)  in three separate 
experiments. A/J mice were immunized with 50-100 nmol of myhc~x(334-352), myhcJ3(334-352), or cardiac myosin and the degree of  inflammation in 
the hearts was determined as described in Materials and Methods.  (B) Photomicrographs  of cross-sections of hearts stained with hematoxyhn and eosin 
obtained from mice from experiment 1 (Fig. 4 A) immunized with either 100 ~g of myosin (a and b), or 100 nmol myhcr~(334-352) (c and d). All mag- 
nifications are 200. (a) Normal,  myosin-immunized. (b) Moderate myocarditis, myosin immunized.  (c) Moderate myocarditis, myhccx(334-352) immu- 
nized. (d) Severe myocarditis, myhcc~(334-352) immunized. Estimates of the severity of myocarditis are made based on examination of the entire cross- 
sectional area, as described in Materials and Methods. 
sition 341  (Fig.  5  A)  (30).  To  ascertain  if these  sequence 
variations  affected  the  immunogenicity  of  the  myhccx- 
(334-352)  epitope,  we generated the corresponding deter- 
minant from  the  myhc[3  sequence.  The  myhc[3(335-348) 
peptide  did  not stimulate  the  Seu.5  T  cells  at  concentra- 
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tions as high as  100  ~M  (Fig.  5  B).  Similarly, the myhc[3- 
(334-352) peptide did not stimulate Seu.5 T  cells (data not 
shown). These findings demonstrated that Seu.5 specifically 
recognized  the  myhccx(334-352)  isoform.  To  identify 
which of the amino acid differences between these two se- A 
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Figure 5.  Fine specificity of the myhcoL(334-352) epitope. (A) Comparison of myhccx(334-352) to other myosins. The sequence of myhc~x(334-352) 
epitope compared to the corresponding region in other myosin molecules (upper  ha~ and myhc0t(335-348) and related peptides (lower  ha~ are shown us- 
ing standard one-letter amino acid codes. The "-" indicates identity to the myhco~(334-352) sequence with the amino acid differences being shown. 
myhclx, mouse cardiac myosin heavy chain eL isoform (27); myhc[3, mouse cardiac myosin heavy chain [3 isoform (Beisel, K.W., personal communica- 
tion); rmyhcct, rat cardiac myosin heavy chain cx isoform (30); myhcJ3, rat cardiac myosin heavy chain [3 isoform (30); rmyhse, rat embryonic skeletal 
muscle myosin isoform (40). Peptides containing substituted amino acids are designated by the position and the substituted residue. (B) Seu.5 stimulation 
by myhcot(334-352) and related peptides. Seu.5 T cells (105) were stimulated with CH27 (3 ￿  10  4) APC and various concentrations of the indicated 
peptides shown in A, as described in Fig. 1 A. The values represent the mean of triplicate determinations with the standard deviations not exceeding 15% 
of the mean. Identical results were obtained in three separate experiments.., myhcot(335-348); O, myhcB(335-348); [], myhcet(335-348)G341; [B, 
myhcot(335-348)P344; gR, myhc~t(335-348)N348. 
quences were  responsible  for this  specificity,  singly substi- 
tuted  peptides  were  generated  (Fig.  5  A).  We  used  the 
myhcot(335-348)  sequence  for this  analysis because  it was 
fully stimulatory, thereby eliminating positions 349 and 350 
from  study.  Of the  three  remaining  positions  which  dif- 
fered  between  the  myhc0~  and  myhc[3  sequences,  two  of 
the  residues,  A344  and  A348,  appeared  to  be involved in 
this isoform specificity. Substitution  at either position with 
the  corresponding  myhc[3  residue  significantly  decreased 
the ability of the peptides to stimulate Seu.5  T  cells (Fig.  5 
B),  with  A344  being r  and  A348  being  100-fold 
less active. The $341  residue did not appear to be a critical 
residue  because  its  replacement  with  a  G  did  not  signifi- 
cantly affect reactivity (Fig.  5  B).  These findings  indicated 
that  the  recognition  of the  myhcix(334-352)  determinant 
critically involved both P344 and N348 residues. 
Myocarditis Induction by myhcee(3  34--3 52) Is Restricted to the 
myhca Isoform.  The  Seu.5  T  cell  specifically  recognized 
the myhc0t(334-352)  isoform of the determinant.  We next 
ascertained  if this  same  specificity  was  observed  in  myo- 
carditis  induction.  When  A/J  mice were immunized  with 
either  the  myhcot(334-352)  or the  myhc[~(334-352)  pep- 
tides,  we found that the myhc[3(334-352)  peptide  did not 
induce myocarditis, whereas the myhc~x(334-352)  strongly 
induced myocarditis (Fig. 4 A). Therefore, the induction of 
myocarditis was specific to the myhco~ isoform of the 334- 
352 determinant. 
myhcee(335-348)  Epitope  Binds  Stably  to  IA k Molecules. 
The  ability  of autoimmune  disease-inducing  epitopes  to 
bind to MHC  molecules has been demonstrated for only a 
limited  number  of epitopes.  Studies  involving  the  exten- 
sively characterized  MBP(Acl-11)  epitope  showed  that  it 
bound  very weakly to  the  I-A  u molecule,  even  though  it 
could strongly induce  experimental autoimmune  encepha- 
lomyelitis  (31).  A  study  of the  binding  of autoimmune 
disease--related  epitopes  in  Lewis  rats  revealed  that  the 
epitopes  were  intermediate  to  poor  binders  (32).  We 
wanted  to  ascertain  how  strongly  the  myhc0t(334-352) 
epitope  bound  to  the  IA  k  molecules.  There  have  been 
many  I-Ak-restricted  immunogenic  peptides  identified 
(33).  Sequence comparison of the myhccx(334--352)  epitope 
with a panel of I-Ak-restricted epitopes showed homology 
to the  extensively  characterized  HEL(48-61)  determinant. 
This  homology  was  in  the  I-Ak-binding  residues,  D338 
and K348, which correlated with D52 and R61  residues of 
HEL(48-61),  respectively.  Our  previously  shown  data 
demonstrated  that  myhc0t(334-352)  stimulated  the  I-A  k- 
restricted Seu.5 T  cell (Fig. 2). To ascertain how avidly the 
myhccx(334-352)  epitope  bound  to  the  I-A  k molecule,  a 
direct binding assay was performed (Fig. 6 A). These stud- 
ies  revealed  that  the  myhcot(334-352)  epitope  bound 
strongly to I-A  k. This binding was stronger than shown for 
the  immunodominant  I-Ak-restricted  epitope,  bovine 
RNase(43-56)  (17),  but  was  weaker  than  the  canonical 
I-A  k binder,  HEL(48-62)  (22, 23).  Thus,  in contrast to the 
MBP(Ac1-11),  the myhcot(335-348)  epitope bound strongly 
to its restriction element. 
Immunodominant  l-Ak-binding  peptides induce  a  con- 
forrnational stability upon the  I-A  k molecule which  can be 
determined  by SDS/PAGE  analysis.  This  stability  directly 
correlates  with  the  half-life  of the  peptide  binding  to  the 
I-A  k molecule  on the surface of APCs and to their inmm- 
nogenicity.  Thus,  immunodominant  determinants  of anti- 
gens induce the SDS-stable conformation of I-A  k and have 
long  half-lives  on  the  surface  of APC.  The  myhcot(335- 
348)  determinant  contained  a  D  residue  at  position  338, 
which  would  be  predicted  to  facilitate  stable  I-A  k fomla- 
tion  (34).  The  myhccl(334-352)  peptide  was  radiolabeled 
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Binding of myhc~(334--352) to purified I-A  t mole- 
cules using a competitive binding assay as described 
in Materials and Methods. The values represent the 
percent maximum cpm bound of  the HEL(YE52-61) 
peptide to I-A  t in the presence of the indicated con- 
centrations of unlabeled HEL(YE52-61) (YEDY- 
GILQINSR), myhcoe(334-352) (DSAFDVLSFTAE- 
EKAGVYK), or RNase(43--56) (VNTFVHESLADV- 
QA). The maximum binding in the absence of com- 
petitors was 148,469 cpm. The values represent a sin- 
gle determination. The  relative ICs0 values of the 
three different peptides were HEL(YE52-61) =  1.0, 
myhcct(334-352) =  15.6, and RNase(43-56) = 33.3. 
These results were confirmed in two separate experi- 
ments.  E],  HEL(46--61); ,,  myhc~(334-352); ￿9 
RNase(43--56). (B) myhc~x(334-352)  induces an SDS- 
stable conformation of I-A  t. An autoradiogram of a 
10% SDS-PAGE gel of lysates from M 13.C3.F6 cells 
incubated for 4 h with  12SI-labeled HEL(48-61) (DGSTDYGILQINSR) which induced stable I-A  t  formation, HEL (48-61)-R52(DGSTR.YGIL- 
QINSR.) and HEL (48-61)-A52 (DGSTAYGILQINSR) unstable inducers, or myhccl(334-352). The expected position of the SDS stable intact ~x/[3 
heterodimer and the unstable I-A  k molecules are indicated. The left-most lane contained molecular mass markers of 106,000, 80,000, 49,500, 32,500, 
27,500, and 18,500 kD. Identical results were obtained in two individual experiments. 
on  the  Tyr350  residue  and  tested  for its  ability  to induce 
the SDS-stable conformation of the I-A  k molecules on the 
surface  of live  I-Ak-expressing  APCs.  The  myhc~x(334- 
352)  induced the  formation of SDS-stable  I-A  k molecules 
(Fig. 6 B). The level of stable I-A  k was 50%, demonstrating 
a propensity of myhcot(334-352) to favor stable conforma- 
tions of the  I-A  k molecules.  This  level of stability was less 
than  the  strong stable  inducer,  HEL(48-61)  (96%  stable), 
but significantly higher than  unstable  variants  of HEL(48- 
61)  (21% stable).  These  findings  showed that the  myhcoL- 
(335-348)  determinant  bound to I-A  k with a good affinity 
and with  a  reasonable  propensity to  form a  stable  confor- 
mation.  When  APC  were  pulsed  with  the  myhcoL(335- 
348) peptide in tissue culture assays,  the Seu.5 T  cells were 
strongly stimulated  (data  not shown),  providing additional 
support  of the  mychot(334-352)  epitope  behaving  as  a 
dominant  epitope.  These  findings  are  also  consistent  with 
our biological observations that this  determinant  is  consti- 
tutively expressed on APC in the heart. 
Discussion 
In these studies we identified an autoantigenic epitope of 
mouse cardiac myosin heavy chain, myhclx(334-352). This 
epitope induced myocarditis comparable to that induced by 
native cardiac myosin, indicating that it was the major au- 
toantigenic  determinant  of myhcot in A/J mice.  The basis 
for the  cardiac  specificity of autoimmune  myocarditis was 
provided by the sequence of the myhc~x(334-352) determi- 
nant,  being  uniquely  expressed  in  myhco~ and  not  in  the 
myhc[3  or  in  skeletal  muscle  myosins.  The  myhco~(334- 
352)  epitope  bound  strongly  to  purified  I-A  k  and  had  a 
good propensity to form stable complexes on the surface of 
live APCs. 
The  steps involved in  the induction  of an autoimmune 
disease  are  complicated  and  most likely heterogeneous  in 
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nature.  Simplistic  views  of the  normal  mechanisms  in- 
volved in preventing autoimmune  disease  involve  the ab- 
sence of a key component, such as the T  cells or the anti- 
gen. Thus, under normal situations the autoreactive T  cells 
would  not  exist,  and  some  type  of failure  in  tolerance 
would  allow  these  T  cells  to  persist.  Our  studies  have 
clearly shown that myosin-specific autoreactive T  cells are 
present in normal animals,  thus the failure of normal mice 
to  spontaneously develop  myocarditis  cannot be  due  to  a 
lack of the autoreactive T  cells.  Prevention ofautoimmune 
reactions by sequestering the autoantigen from the immune 
system  is  another  related  possibility.  This  sequestration 
model  contends  that  tissue  injury,  release  of the  self anti- 
gen, and subsequent exposure to the immune system would 
result in autoimmunity.  This mechanism could be operat- 
ing for antigens such as MBP which are sequestered by the 
blood-brain  barrier.  However,  the  demonstration  that  a 
precursor of MBP  is  expressed  in  the  thymus complicates 
the interpretation for the existence ofMBP-reactive T  cells 
(35). Sercarz and his colleagues have proposed that autoan- 
tigenic  epitopes  are  part  of the  cryptic  self repertoire  and 
that dominant self epitopes induce tolerance (36). 
In autoimmune myocarditis, we have convincingly shown 
that  inaccessibility of the  autoantigen  to  the  immune  sys- 
tem  or being part  of the  cryptic self repertoire  cannot be 
the  explanation  for the lack of stimulation  of the myosin- 
reactive T  cells.  Our previous studies clearly demonstrated 
that  cardiac  myosin was  constitutively processed  and pre- 
sented on APCs in the heart.  In the work presented in this 
report,  we  have  identified  an  epitope  of myosin that  can 
induce myocarditis by using an I-Ak--restricted myosin-spe- 
cific T  cell  hybridoma as  a  functional probe.  Though we 
do not have direct evidence that this hybridoma came from 
a T  cell clone capable of inducing myocarditis, we believe 
Seu.5 is representative  of a pool of myocarditis-inducing T 
cells  because  its  stimulating  epitope  myhccx(334-352)  is constitutively expressed on cardiac APC  and causes  myo- 
carditis when injected into A/J mice. We have shown that 
the myocarditis-inducing epitope, myhcoL(334-352), binds 
strongly to I-A  k molecules and induces a stable  conforma- 
tion. This stable  conformation of I-A  k has been previously 
shown to result in long-lived complexes on the surface of 
APC,  and correlates directly with the immunodominance 
of the  epitope.  The  finding  that  334-352  induces  stable 
I-A  k molecules supports our observation that the myhco~- 
(334-352)/I-A  k complexes are expressed constitutively on 
APC in the heart. 
These results  indicate that autoimmune disease-inducing 
epitopes can bind strongly and stably to the MHC mole- 
cules.  Thus, the myhc0~(334-352) epitope is constitutively 
accessible  to the immune system in an immunodominant 
manner,  and  the  mechanism  preventing  myocarditis  in 
normal mice is not due to either the lack of  myosin-specific 
T  ceils or the availability of the myhccl(334-352) epitope. 
Therefore, the  view  that  the  prevention of autoimmune 
reactions is due to the absence of either the T  cells or avail- 
able antigen appears to be too simplistic with regard to au- 
toimmune myocarditis. Our findings would clearly indicate 
that it must be the activation state of the T  cells, the APC, 
or the local environment in the heart, which normally pre- 
vents autoimmunity in the heart. 
The identification of the myhc(x(334-352) epitope as a 
dominant myocarditis-inducing epitope permitted further 
characterization of the myosin-induced myocarditis model. 
These findings clearly demonstrate that the disease-induc- 
ing autoantigen is cardiac myosin. The cardiac specificity of 
this disease  can also be explained because the myhco~(334- 
352) epitope is only found in cardiac myosin, not in skele- 
tal muscle myosins, and the constitutively expressed com- 
plexes are not found in other APCs  outside of the heart. 
Interestingly,  myocarditis  induction  by  myhc0~(334-352) 
was specific for the myhcoL isoform, and not the [3 isoform. 
In rodents the  13  isoform predominates in the  heart until 
birth, at which time the e~ isoform then becomes the dom- 
inant cardiac  myhc isoform. After birth,  the  [3 isoform is 
expressed in the ventricles of the heart as well as in other 
noncardiac muscles.  A  simple explanation for our finding 
that  induction  of myocarditis  is  caused  by  the  myhcoL 
epitope, would be that  this  area  of the  myosin molecule 
differs significantly between isoforms of myosin, including 
other muscle myosins and cardiac 13 isoform. The observed 
myhcot specificity may not be due to differences in the [3 
cardiac  isoform  per  se,  but  may  simply  reflect  that  the 
myhcoe(334-352) epitope differs  from the  other myosins, 
whereas the myhc[3(334-352) determinant is similar to all 
of the other forms of myosin. Thus, the mice would be tol- 
erant  in  this  region  to  other  forms  of myosin,  except 
myhcci. Another more interesting possibility would be that 
somehow there is a difference in the level of tolerance to 
the  different myhc isoforms.  There could be more com- 
plete tolerance to the 13 isoform than the o~, resulting in the 
deletion of the self-reactive T  cells which could recognize 
the  13 isoform. Perhaps,  the recognition of the  [3 isofonn 
during fetal and neonatal life by the  developing immune 
system  results  in  more  efficient tolerance  induction,  be- 
cause the (i isoform is not expressed until after birth. Thus, 
this would be an example of a tolerance being affected by a 
developmentally expressed self-antigen.  Obviously further 
studies must be performed to determine if tolerance due to 
differential developmental expression of the o~ and [3 cardiac 
myosin isoforms is directly related to the disease process. 
The myhco~(334-352) epitope, located in  the  $1  head 
region, has not been previously implicated in any immuno- 
logical studies  involving cardiac myosin.  Wegmann  et al. 
identified two myocarditogenic epitopes in rats, comprised 
of residues 1304-1320 and 1539-1555  (37).  Liao et al. us- 
ing bacterially expressed fragments  of rat  cardiac  myosin 
heavy chains,  concluded that some of the pathogenic epi- 
topes of myosin resided in the  $2  subunit,  residues 736- 
1032 in BALB/c mice (38). The myhcot(334-352) epitope 
identified in this report represents an immunodominant au- 
toantigenic T  cell epitope in A/J mice and most likely in 
other I-Ak--expressing  strains;  however, other epitopes of 
myosin are likely involved in this disease  in strains  of mice 
possessing  different MHC alleles. 
A  key  finding  from  this  work  is  that  autoantigenic 
epitopes can behave like immunodominant epitopes, bind 
strongly to  the  class  II  molecules,  and  remain  stably  ex- 
pressed on the surface of an APC. Sette and colleagues (39) 
and Buus  and  colleagues  (32)  have  made similar conclu- 
sions that autoantigenic epitopes do not necessarily have to 
be poor binders. These findings suggest that there is heter- 
ogeneity in  the biochemical nature  of autoantigenic  epi- 
topes with myhc0t(334-352) representing one group,  and 
the MBP Ac1-11  representing another.  The difference in 
stability of these epitopes binding to their respective restric- 
tion elements could indicate that different mechanisms may 
be responsible for the self-reactive T  cells in the different 
autoimmune diseases.  It is intriguing to speculate that the 
mechanism  involved  in  myocarditis  induction  would  be 
the  developmental expression of the different isoforms of 
the  cardiac myosin heavy chain,  with  the myhcot, which 
contains the disease  inducing epitope, not being expressed 
until birth and only in the heart. 
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